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BRK1: BRICK1, SCAR/WAVE Actin-Nucleating Complex Subunit 
F-actin: filamentous actin 
miRNA: microRNA 
shRNA: short hairpin RNA 
TCR: T cell receptor 
WAVE: Wiskott-Aldrich Syndrome Protein (WASP) Family Verprolin-Homologous Protein  
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Abstract 
MicroRNAs are short endogenous non-coding RNAs that play pivotal roles in a diverse range 
of cellular processes. The miR-181 family is important in T cell development, proliferation 
and activation. In this study, we have identified BRK1 as a potential target of miR-181c using 
a dual selection functional assay and have showed that miR-181c regulates BRK1 by 
translational inhibition. Given the importance of miR-181 in T cell function and the potential 
role of BRK1 in the involvement of WAVE2 complex and actin polymerization in T cells, we 
therefore investigated the influence of miR-181c-BRK1 axis in T cell function. Stimulation of 
PBMC derived CD3
+
 T cells resulted in reduced miR-181c expression and upregulation of 
BRK1 protein expression, suggesting that miR-181c-BRK1 axis is important in T cell 
activation. We further showed that overexpression of miR-181c or suppression of BRK1 
resulted in inhibition of T cell activation and actin polymerization coupled with defective 
lamellipodia generation and immunological synapse formation. Additionally, we found that 
BRK1 silencing led to reduced expressions of other proteins in the WAVE2 complex, 
suggesting that the impairment of T cell actin dynamics were a result of the instability of the 
WAVE2 complex following BRK1 depletion. Collectively, we demonstrated that miR-181c 
reduces BRK1 protein expression level and highlighted the important role of miR-181c-
BRK1 axis in T cell activation and actin polymerization-mediated T cell functions.   
 4 
Introduction 
MicroRNAs (miRNAs) are short endogenous non-coding RNAs which influence gene 
expression and play pivotal roles in a diverse range of cellular processes [1, 2]. We focused 
on the miR-181 family which has previously been reported to play an important role in T cell 
functions [3-5]. The miR-181 family consists of four members, miR-181a, miR-181b, miR-
181c and miR-181d. miR-181a and miR-181b are localized on chromosome 1 (1q32.1) and 
chromosome 9 (9q33.3), while miR-181c and miR-181d are localized on chromosome 19 
(19p13.12) [6]. miR-181a is an intrinsic modulator of the T cell receptor (TCR) signaling 
pathway by downregulating multiple negative regulators (phosphatases such as PTPN22, 
SHP-2 and DUSP6) in the TCR signaling pathway. This dampens LCK and ERK signaling 
which in turn enhances the T cell activation [3]. Furthermore, miR-181a/b-deficient mice 
have a reduced number of T cells suggesting that miR-181a and miR-181b may be important 
in T cell development [4]. Overexpression of miR-181c in Jurkat and CD4
+
 T cells was found 
to impair T cell activation and proliferation by reducing IL-2 expression [5].  
BRK1 (BRICK1, SCAR/WAVE Actin-Nucleating Complex Subunit) is a component of the 
WAVE [Wiskott-Aldrich Syndrome Protein (WASP) Family Verprolin-Homologous Protein] 
complex that plays a critical role in actin nucleation [7]. The WAVE regulatory complex at 
the N-terminal of WAVE protein consists of WAVE1/2/3, ABI1/2/3, SRA1, HEM1/2 and 
BRK1 [8, 9]. WAVE protein is a member of the WASP family, which recruits actin 
monomers (G-actin) and triggers conformational changes in ARP2/3 complex, thereby 
promoting production of branched networks of filamentous actin (F-actin) [7, 10].  
The ability of T cells to polymerize actin is critical from the very first step of TCR 
engagement to the completion of a successful T cell activation [11]. Among the three 
isoforms of WAVE [12, 13], WAVE2 has been shown to be the major isoform expressed in T 
cells [14, 15] and increasing data has indicated that it is an essential regulator of multiple 
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actin cytoskeleton-dependent processes during T cell activation [14-17]. Suppression of 
WAVE2 in Jurkat T cells has been shown to reduce the F-actin accumulation at the 
immunological synapse, decrease conjugate formation and cause defects in stable 
lamellipodia generation [14, 15]. In addition, loss of WAVE2 in Jurkat T cells also led to 
reduction in IL-2 promoter activity and impairment in the regulation of Ca
2+
 [14]. 
Furthermore, silencing of WAVE2 also caused defective integrin-mediated adhesion in 
primary CD4
+
 T cells and Jurkat T cells in response to TCR activation [16, 17].  
We identified the potential targets of miR-181c/d using an in-house functional assay [18]. 
This assay depends upon the functional activity rather than relying solely on the 
complementary binding of a miRNA to its putative target [19, 20]. In addition, this 
methodology is also able to identify targets that are downregulated by mRNA degradation or 
translational repression [18]. In this study, we focused on validating the downstream targets 
of miR-181c and investigating the biological functions of the identified targets. We 
demonstrated that the miR-181c-BRK1 axis plays an indispensable role in regulating T cell 
actin dynamics and thus is important in T cell activation, lamellipodia generation and 
immunological synapse formation.  
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Materials and Methods 
Cell culture  
Adherent cell lines (MCF7 and HeLa) were cultured in Dulbecco modified essential medium 
(DMEM) (Thermo Fisher Scientific, Waltham, MA, USA) whilst the suspension cell line 
(Jurkat T cells) was cultured in RPMI 1640 medium (Thermo Fisher Scientific). Both media 
were supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO, USA) 
and 1% L-Glutamine-Penicillin-Streptomycin solution (Sigma-Aldrich). Isolation of primary 
CD3
+
 T cells from peripheral blood mononuclear cells (PBMC) was performed using 
Dynabeads
®
 Untouched
TM
 Human T Cell Kit (Thermo Fisher Scientific). Isolated CD3
+
 T 
cells were cultured in X-Vivo
TM
15 medium (Lonza, Basel, Switzerland) supplemented with 
2% human AB serum (Sigma-Aldrich) and 100U/ml recombinant human IL-2 (PeproTech, 
Rocky Hill, NJ, USA). Cells were cultured under humidified conditions at 37°C in 5% CO2. 
Stimulation of Jurkat T cells was achieved with 10μg/ml of plate bound anti-human CD3 
(clone OKT3; eBioscience, San Diego, CA, USA) and 25ng/ml of phorbol 12-myristate 13-
acetate (PMA; Sigma-Aldrich) whilst primary T cells were stimulated with 2μg/ml of plate 
bound anti-human CD3 (clone OKT3; eBioscience) and 2μg/ml of soluble anti-human CD28 
(clone 28.2; eBioscience). 
Functional assay for miR-181c/d target identification 
Functional assay to identify the target genes of miR-181c/d was performed as previously 
described [18]. The 3’UTR cDNA target ID library (MREH01; Sigma-Aldrich) derived from 
multiple human tissues and 10 human cell lines, representing 16,923 unique genes, was 
cloned downstream of a thymidine kinase-zeocin (TKzeo) fusion gene into in the p3’TKzeo 
vector, conferring zeocin resistance and ganciclovir (GCV) sensitivity. MCF7 cell line, 
expressing low levels of miR-181c and miR-181d, was transfected with this cDNA library 
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and selected with 100μg/ml zeocin (InvivoGen, San Diego, CA, USA), which results in a 
population of cells that express the TKzeo fusion gene from stably integrated library 
constructs. Expanded zeocin resistant cells were hence transfected with pBabePuro plasmid 
expressing miR-181c/d. After selection for stable integration with 2μg/ml puromycin 
(InvivoGen) and cell expansion, cells underwent subsequent GCV counter-selection. 
Genomic DNA was isolated from the expanded GCV resistant cells using Quick-gDNA
TM
 
MiniPrep Kit (Zymo Research, Irvine, CA, USA) and the cDNA containing miR-181c/d 
target sites was PCR amplified using p3’TKzeo specific primers flanking the cloning site 
(forward: 5’-GGGTCGACCTCGAATCCTTA-3’; reverse: 5’-
CGAGGCGGCCGACATGTTT-3’). Amplified bands were purified, sequenced and aligned 
against human genome and transcript database in NCBI Nucleotide Blast to identify the 
putative targets of miR-181c/d. miRNA target identification and validation were performed as 
previously described [18]. 
Cell transfection and transduction 
Ectopic expression of miR-181 in MCF7, HeLa and Jurkat T cells was performed by 
transfecting the cells with 2μg of pBabePuro plasmid expressing miR-181 using Ingenio® 
Electroporation Kit (Mirus Bio LLC, Madison, WI, USA). Cells transfected with empty 
pBabePuro vector were used as negative control. Transfected cells were then selected with 
2μg/ml puromycin (InvivoGen). Transient transfection of cells with 100nM hsa-miR-181c-5p 
miRIDIAN hairpin inhibitor and negative control (Dharmacon, Lafayette, CO, USA) were 
also performed using the Ingenio
®
 Electroporation Kit (Mirus Bio LLC). Suppression of 
BRK1 in Jurkat and primary T cells was achieved by transducing the cells with short hairpin 
RNA (shRNA) lentiviral vectors (pLKO.1-shBRK1_1 and pLKO.1-shBRK1_2) in the 
presence of 4µg/ml of polybrene (Sigma-Aldrich). Cells transduced with pLKO.1-scrambled 
shRNA were used as negative control. For primary T cells, cells were stimulated with 2μg/ml 
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of plate bound anti-human CD3 (clone OKT3; eBioscience) and 2μg/ml of soluble anti-
human CD28 (clone 28.2; eBioscience) before lentivirus transduction. shRNA lentivirus were 
generated by co-transfection of the human embryonic kidney HEK293T cell line with four 
plasmids; pMDG (envelope plasmid encoding VSV-G), pRRE (packaging plasmid encoding 
Gag & Pol), pREV (packaging plasmid encoding REV) and the shRNA plasmids (pLKO.1-
shBRK1_1, pLKO.1-shBRK1_2 or pLKO.1-scrambled shRNA) using Calcium Phosphate 
Transfection Kit (Thermo Fisher Scientific). 
Dual luciferase activity assay 
Full length BRK1 was inserted downstream of a firefly luciferase gene (luc2) in the 
pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega, Madison, WI, 
USA). The pmirGLO-BRK1 construct was then transfected into miR-181c overexpressing 
MCF7, HeLa and Jurkat T cell lines. Transfection in MCF7 and HeLa cells were done using 
Ingenio
®
 Electroporation Kit (Mirus Bio LLC) while transfection of Jurkat T cells was 
performed using Lipofectamine 2000 (Thermo Fisher Scientific). Firefly and renilla 
luciferase activities were measured 24 hours after transfection using the Dual-Glo
®
 
Luciferase Assay System (Promega). Normalized data were calculated as the ratio of 
firefly/renilla luciferase activities.  
Flow cytometry analysis 
Surface staining was performed with anti-human CD69-PE (eBioscience), Pacific Blue
TM
 
anti-human CD69 (BioLegend, San Diego, CA, USA) and anti-human CD154-PE 
(eBioscience) for an hour in the dark. F-actin was stained with rhodamine phalloidin (Thermo 
Fisher Scientific). Stained cells were washed and resuspended in FACS buffer (2.5% FBS in 
PBS) and analyzed on a BD FACSCanto II (BD Biosciences, San Jose, CA, USA). FlowJo 
Version 9.7.7 software (Tree Star, Ashland, OR, USA) was used to perform data analysis.  
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Spreading assay 
8-well chamber culture slides (BD Falcon, San Jose, CA, USA) were coated with 0.01% 
poly-L-lysine solution (Sigma-Aldrich) for 15 minutes at room temperature and subsequently 
with 10µg/ml anti-human CD3 (clone OKT3; eBioscience) overnight at 4°C. 0.5×10
6 
 (for 1 
minute of spreading) or 0.2×10
6 
(for 3 and 5 minute of spreading) cells were plated gently 
onto the slides and allowed to spread for 1, 3 or 5 minutes. Cells were fixed with 4% 
paraformaldehyde for 30 minutes, permeabilized with 0.1% Triton X-100 in PBS for 5 
minutes and blocked with 5% goat serum in 10% FBS/0.02% sodium azide in PBS for an 
hour. Cells were then stained with rhodamine phalloidin (Thermo Fisher Scientific) 
according to the manufacturer’s instructions. After washing, the cell specimens were 
mounted with Vectashield Mounting Medium with DAPI (Vector Laboratories, Burlingame, 
CA, USA). Slides were analyzed using Leica DM4500B fluorescence microscope (Leica 
Microsystems, Wetzlar, Germany) with a 100× oil objective. Images were acquired using a 
Leica DFC365 FX monochrome digital camera and Leica LAS AF software. Percentage of 
spreading was calculated by counting at least 100 cells per experimental condition. Cells that 
form an F-actin ring at the cell periphery were scored as positive while cells without an F-
actin ring were scored as negative.  
Immunological synapse assay 
MEC-1 B cells were stained with CellTracker Blue CMAC (Thermo Fisher Scientific) 
according to the manufacturer’s instructions and pulsed with 2μg/mL of a cocktail of 
staphylococcal superantigens (sAgs; SEA and SEB; Sigma-Aldrich) for 30 minutes at 37°C. 
1×10
6
 of B cells were centrifuged at 200×g for 5 min with an equal number of T cells and 
incubated at 37°C for 15 minutes. Cells were transferred onto microscopic slides (Menzel-
Glaser Polysine slides; Thermo Fisher Scientific) using a cell concentrator and fixed with 3% 
methanol-free formaldehyde (TABB Laboratories, Berks, England) in PBS for 15 minutes. 
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Subsequently, cells were permeabilized with 0.3% Triton X-100 in PBS for 5 minutes and 
treated with blocking buffer (0.1% BSA in PBS) for 10 minutes. F-actin was stained with 
rhodamine phalloidin (Thermo Fisher Scientific) according to the manufacturer’s 
instructions. After washing, the cell specimens were sealed with 22mm×32mm coverslips 
using fluorescent mounting medium (Dako, Glostrup Municipality, Denmark). Medial optical 
section images were captured using an A1R confocal microscope (Nikon, Minato, Tokyo, 
Japan) with a 60×/1.40 oil objective by NIS-elements imaging software (Nikon). Detectors 
were set to detect an optimal signal below saturation limits. Fluorescence was acquired 
sequentially to prevent passage of fluorescence from other channels (Multi-Track). Image 
sets to be compared were acquired during the same session using identical acquisition 
settings. Blinded confocal images were analyzed using NIS-elements imaging software 
(Nikon). T cell-B cell conjugates were identified only when T cells were in direct contact 
interaction with B cells (blue fluorescent channel) and the total area (in square micrometers) 
of F-actin (red fluorescent channel) accumulation at all T cell contact sites and synapses with 
B cell was measured.  
Quantitative real time PCR  
Total RNA was extracted from cells using TRIzol (Thermo Fisher Scientific) method or 
RNeasy
®
 Micro Kit (Qiagen, Germantown, MD, USA). For quantification of BRK1 mRNA 
expression, first strand cDNA was synthesized using SuperScript® VILO™ cDNA Synthesis 
Kit (Thermo Fisher Scientific) and quantitative real time PCR (qPCR) analysis was carried 
out using the FastStart Universal Probe Master (ROX) and Universal Library Probes (Roche 
Diagnostics, Atlanta, GA, USA). The details of primers and probes used are shown in 
Supplemental Table 1. BRK1 expression levels, normalized to GAPDH, were quantified with 
the relative quantification method (2
-Ct
). For miRNA expression quantification, reverse 
transcription of miRNA was first carried out using Universal cDNA Synthesis Kit II (Exiqon, 
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Vedbæk, Denmark) and qPCR analysis was then performed using ExiLENT SYBR
®
 Green 
Master Mix (Exiqon). Details of miRNA specific primer mix are shown in Supplemental 
Table 1. The miR-181 levels were normalized to miR-103a and expressed as relative 
quantification (2
-Ct
). 
Western blot analysis 
Whole cell lysates were prepared using 1× Radio-Immunoprecipitation Assay (RIPA) Lysis 
Buffer (Santa Cruz Biotechnology, CA, USA). 15-20µg of lysates were separated on 
NuPAGE
TM
 Novex
TM
 4-12% Bis-Tris Protein Gels (Thermo Fisher Scientific), transferred to 
a PVDF membrane (Bio-Rad Laboratories, Hercules, CA, USA) and blocked with 5% non-
fat dried milk in 0.1% Tween 20/PBS buffer for an hour. Membranes were then probed with 
mouse monoclonal anti-β-ACTIN (ab8226; Abcam, Cambridge, UK), mouse monoclonal 
anti-BRK1 (generous gift from Professor Stradal Theresia), rabbit polyclonal anti-WAVE2 
(H-110; Santa Cruz Biotechnology), mouse monoclonal anti-ABI1 (C-1; Santa Cruz 
Biotechnology), rabbit polyclonal anti-PIR121-1/Sra-1 (EMD Millipore, Billerica, MA, 
USA), goat polyclonal anti-HEM1 (Q-12; Santa Cruz Biotechnology), rabbit polyclonal anti-
ARP2 (H-84; Santa Cruz Biotechnology) and rabbit polyclonal anti-ARP3 (EMD Millipore) 
overnight at 4°C. After washing, membranes were subsequently probed with HRP-linked 
anti-rabbit IgG (Cell Signaling Technology, Danvers, MA, USA), HRP-linked anti-mouse 
IgG (Promega) and HRP-linked rabbit anti-goat IgG (Dako) for an hour at room temperature. 
Membranes were then incubated in Pierce
TM
 ECL Western Blotting Substrate (Thermo Fisher 
Scientific) for 5 minutes and proteins were exposed to CL-Xposure
TM
 Clear Blue X-ray Film 
(Thermo Fisher Scientific) for the preferable time using Photon Imaging Systems SRX-101A. 
Protein expression levels were quantified by Image Studio
TM
 Lite Version 5 software (LI-
COR Biosciences, Lincoln, NE, USA) against loading control (β-ACTIN) according to the 
band intensity.  
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Statistical analysis 
Statistical analysis was performed using Prism Version 5 software (GraphPad Software Inc, 
La Jolla, CA, USA). Statistical significance was calculated by P value using unpaired t-test. 
P values <0.05 were considered statistically significant. Error bars were generated based on 
two to four independent experiments.  
Online supplemental material 
The online supplemental material consists of one supplemental table and four supplemental 
figures. 
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Results  
miR-181c regulates BRK1 protein expression 
To identify putative targets of miR-181c/d, we employed a functional screening assay which 
has been developed in-house [18]. cDNAs potentially targeted by miR-181c/d were PCR 
amplified from genomic DNA isolated from GCV resistant cells (Supplemental Figure 1A). 
Amplified bands were purified, sequenced and aligned against human genome and transcript 
database. A major transcript identified was BRK1 (Supplemental Figure 1B).  
Since miR-181a, miR-181b, miR-181c and miR-181d have the same seed sequence and they 
might regulate the same genes, we overexpressed miR-181a, miR-181b, miR-181c and miR-
181d in three independent cells lines, MCF7, HeLa and Jurkat T cells (Figure 1A) in order to 
determine the mRNA and protein expressions of BRK1. We found that ectopic expressions of 
miR-181a, miR-181b, miR-181c and miR-181d had no impact on BRK1 at the mRNA level in 
all three cell lines (Figure 1B). Nevertheless, BRK1 protein levels in MCF7, HeLa and Jurkat 
T cells were all substantially downregulated upon miR-181c overexpression (Figure 1C-D). 
However, in miR-181a, miR-181b and miR-181d overexpressing cells, the protein level of 
BRK1 was not altered (Figure 1C-D). These results indicate that only miR-181c regulates 
BRK1 protein expression. To further confirm that miR-181c regulates BRK1, miR-181c 
overexpressing MCF7, HeLa and Jurkat T cells underwent miR-181c inhibition by 
transfecting with miRIDIAN hairpin inhibitor directed against miR-181c. Analogous to miR-
181c overexpression, BRK1 expression remained unchanged at the mRNA level following 
miR-181c inhibition (Figure 1E). However, reduced BRK1 protein expression in miR-181c 
overexpressing cells could be reversed with miR-181c inhibition, resulting in a marked 
increase in protein expression of BRK1 (Figure 1F-G). Overall, these data demonstrated that 
overexpression and inhibition of miR-181c had no effect on the mRNA expression level of 
BRK1 but did in fact modulate its protein expression, suggesting that miR-181c regulates 
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BRK1 expression by promoting translational inhibition rather than mRNA degradation. In 
addition, a dual luciferase reporter assay was also performed to further confirm that miR-181c 
regulates BRK1 expression. Luciferase activity from a plasmid with BRK1 cDNA cloned 
downstream of luciferase reduced significantly as a result of enforced expression of miR-
181c in MCF7, HeLa and Jurkat T cells (Figure 1H), indicating that miR-181c represses 
BRK1 expression.  
BRK1 is important for the stability of WAVE2 regulatory complex in T lymphocytes 
In solid tumor cell lines, BRK1 has been shown to play an important role in regulating the 
stability of WAVE regulatory complex [21-23]. To explore whether BRK1 also plays a 
similar role in T lymphocytes, we examined the expressions of other proteins involved in 
WAVE2 complex including WAVE2, ABI1, SRA1 and HEM1 following knockdown of 
BRK1 in both Jurkat and primary T cells. Upon suppression of BRK1, the protein levels of 
WAVE2, ABI1 and SRA1 were significantly reduced (Figure 2). However, HEM1 protein 
expression was not altered by BRK1 depletion in both Jurkat and primary T cells (Figure 2). 
In addition, we also assessed whether BRK1 depletion would influence the levels of the 
components of ARP2/3 complex. We found that the protein expressions of ARP2 and ARP3 
remained unchanged following BRK1 suppression (Figure 2). We also showed that reduced 
expression of BRK1 as a result of miR-181c overexpression in Jurkat T cells decreased the 
WAVE2 protein expression (Supplemental Figure 2). This data suggests that, as in solid 
tumor cell lines, BRK1 is important for the stability of other proteins in the WAVE2 
regulatory complex in T cells.  
miR-181c-BRK1 axis is important for T cell activation 
It has been shown that miR-181c is important in T cell activation [3, 5]. In this study, we 
found that miR-181c regulates the expression of BRK1. BRK1 is a component of the 
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WAVE2 complex which has been shown to be involved in T cell activation by modulating 
processes such as lamellipodia formation, immunological synapse formation, IL-2 promoter 
activity, integrin activation and Ca
2+
 entry [14-17]. Therefore, to study whether the regulation 
of BRK1 by miR-181c correlates with T cell activation, we examined the expression of miR-
181c and BRK1 in PBMC derived CD3
+
 T cells before and after co-stimulation with CD3 
and CD28 antibodies. Following co-stimulation, the expression of miR-181c was reduced 
(Figure 3A) and BRK1 protein expression was upregulated (Figure 3B-C), suggesting that the 
miR-181c-BRK1 axis is important in T cell activation. To further examine the role of miR-
181c-BRK1 axis in T cell activation, we overexpressed miR-181c (Supplemental Figure 3) 
and suppressed BRK1 (Figure 3D) in Jurkat T cells. Subsequently, we analyzed the 
expression of CD69, a marker for T cell activation. Upon stimulation, the CD69 expression in 
Jurkat T cells was elevated as compared to its expression before stimulation. However, in the 
miR-181c overexpressing Jurkat T cells, the upregulation of CD69 expression was lower in 
comparison to control (Figure 3E). To quantitatively determine the effect of miR-181c 
overexpression on T cell activation, the mean fluorescence intensity (MFI) was analyzed 
indicative of CD69 expression. Following stimulation, the relative MFI of CD69 staining was 
increased both in control and miR-181c overexpressing cells in comparison to before 
stimulation. Nevertheless, the miR-181c overexpressing cells have a significantly lower 
increment of CD69 MFI as compared to control (Figure 3F). Similarly, the increment of 
CD69 expression in BRK1-suppressed Jurkat T cells (shBRK1_1 and shBRK1_2) was lower 
as compared to scrambled (Figure 3G-H). In addition, knockdown of BRK1 was also 
performed in primary T cells (Supplemental Figure 4) where expression of CD69 (Figure 3I-
J) and CD154 (Figure 3K-L) was also impaired following stimulation. Together, these data 
indicate that enforced expression of miR-181c or silencing of BRK1 reduces CD96 and 
CD154 expression suggesting that miR-181c-BRK1 axis is involved in T cell activation. 
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miR-181c-BRK1 axis is required for actin polymerization in T cells 
Reorganization of the actin cytoskeleton is a requisite event in controlling T cell activation 
and is critical for multiple aspects in T cell function [11]. Our finding on the involvement of 
miR-181c-BRK1 axis in T cell activation has led us to investigate whether F-actin 
polymerization during T cell activation is altered following ectopic expression of miR-181c 
and silencing of BRK1. We analyzed the total cellular F-actin content in miR-181c 
overexpressing and BRK1-silenced Jurkat and primary T cells before and after stimulation. 
Upon stimulation, the total cellular F-actin content in both control-transfected and miR-181c 
overexpressing Jurkat T cells was increased. However, a lower increment of the total cellular 
F-actin content was observed in miR-181c overexpressing cells in comparison to control 
(Figure 4A). To quantitatively determine the effect of miR-181c overexpression on actin 
polymerization, the MFI was analyzed indicative of the total cellular F-actin content. The 
relative MFI of F-actin staining was elevated in both control-transfected and miR-181c 
overexpressing Jurkat T cells following stimulation. Nonetheless, the miR-181c 
overexpressing cells have a significantly lower increment of F-actin MFI in comparison to 
control (Figure 4B). Similar to miR-181c overexpression, the increment of total cellular F-
actin content in the BRK1-silenced cells was also significantly lower as quantified by MFI in 
both Jurkat (Figure 4C-D) and primary T cells (Figure 4E-F). Collectively, these data suggest 
that the miR-181c-BRK1 axis is required for maximal actin polymerization in T cells. 
miR-181c-BRK1 axis plays a key role in lamellipodia formation in T lymphocytes 
The effects of miR-181c or  BRK1 modulation on the total cellular F-actin content in T cell 
activation have led us to determine whether enforced expression of miR-181c or knockdown 
of BRK1 could have an impact on actin polymerization-mediated T cell functions. Spreading 
of T cells on anti-TCR coated slide requires the formation of stable actin structures and the 
generation of lamellipodia [24]. We thus assessed the ability of T cells to generate 
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lamellipodia using a spreading assay following miR-181c overexpression or BRK1 
suppression. We found that, during the spreading process, miR-181c overexpressing cells 
failed to spread on anti-CD3 coated slides whilst control cells were able to spread in a highly 
ordered fashion, forming a round lamellipodial interface at the cell periphery containing 
radially-arrayed F-actin-rich structures (Figure 5A). At the 1 minute time point, the 
percentage of cells that have spread on anti-CD3 coated slides in both control and miR-181c 
overexpression were all very low. Nevertheless, at 3 and 5 minutes, a significantly lower 
percentage of spreading was observed in miR-181c overexpressing cells as compared to 
control (Figure 5B). Consistent with this finding in miR-181c overexpression, in both Jurkat 
(Figure 5C-D) and primary T cells (Figure 5E-F), a small difference in percentage of 
spreading was seen at 1 minute between control and BRK1-knockdown T cells while 
significant differences were observed after 3 and 5 minutes of spreading where depletion of 
BRK1 had a significant impact on the cell ability to spread in response to anti-CD3 
stimulation. Taken together, these data suggest that the miR-181c-BRK1 axis is required for 
the generation of lamellipodia in response to TCR stimulation, a phenomenon requiring 
proper regulated actin polymerization. 
miR-181c-BRK1 axis plays an important role in immunological synapse formation in T 
cells 
The mutual recognition of the T cell and antigen presenting cell (APC) results in the 
engagement and clustering of the TCR, and the formation of the T cell-APC interface, known 
as the immunological synapse. Regulation of actin polymerization at the immunological 
synapse is crucial to initiate and sustain T cell activation. We therefore analyzed whether 
ectopic expression of miR-181c or suppression of BRK1 could impair actin polymerization at 
the immunological synapse (T cell-B cell conjugation site). Our results showed that 
overexpression of miR-181c in Jurkat T cells led to severe impairment in actin 
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polymerization in response to stimulation with superantigen-pulsed MEC-1 B cells. In 
comparison to control, miR-181c overexpression resulted in a marked reduction of F-actin 
staining at the T cell-B cell contact site (Figure 6A). To quantitatively determine the effect of 
miR-181c overexpression on immunological synapse formation, we measured the total area 
(in square micrometers) of F-actin accumulation at T cell contact sites and synapses with B 
cells where a significant reduction in the total area of F-actin accumulation at T cell-B cell 
contact site was found (Figure 6B). Consistently, we also demonstrated that in both Jurkat 
(Figure 6C-D) and primary T cells (Figure 6E-F), knockdown of BRK1 impaired the actin 
polymerization at the T cell-B cell contact site as shown by significantly reduced F-actin 
staining and total area of F-actin accumulation at the T cell-B cell synapses. Overall, these 
data suggest that the ectopic expression of miR-181c or silencing of BRK1 impairs 
immunological synapse formation, a process that is highly dependent on proper regulation of 
actin cytoskeletal dynamics at the T cell-B cell conjugation site.  
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Discussion 
In this study we show, for the first time, that miR-181c modulates BRK1 by translational 
inhibition. BRK1 is a component of the WAVE complex that regulates actin polymerization 
[7]. It has been confirmed that at the N-terminal of the WAVE protein, a tight pentameric 
complex consisting of WAVE1/2/3, ABI1/2/3, SRA1, HEM1/2 and BRK1 is formed [8, 9]. 
In this study, we showed that upon BRK1 silencing, the protein expression levels of WAVE2, 
ABI1 and SRA1 were reduced in both Jurkat and primary T cells consistent with previous 
studies [21-23]. Derivery and colleagues demonstrated that siRNA knockdown of BRK1 in 
HeLa cells resulted in a reduction of the protein expressions of WAVE2, SRA1, NAP1 and 
ABI1 [21] while in lung cancer PG cell line, Cai et al. reported that loss of BRK1 resulted in 
decreased expression of WAVE2 protein [22]. Suppression of BRK1 in osteosarcoma U2OS 
cell line also contributed to decreased protein expressions of ABI1, WAVE1 and WAVE2 
[23]. Interestingly, we found that the HEM1 protein level was not altered following BRK1 
depletion. This might be due to the fact that BRK1 does not interact directly with HEM1 in 
the WAVE2 complex [8, 21, 25]. Previous studies have shown that BRK1 is a precursor in 
the assembly of WAVE-ABI-BRK1 heterotrimeric complex and in the subsequent binding of 
the heterotrimer to the SRA1-HEM1 dimer in order to form a functional WAVE regulatory 
complex. The binding of the WAVE-ABI-BRK1 heterotrimer to the SRA1-HEM1 dimer is 
mainly via interaction between BRK1 and SRA1 [8, 21, 25]. Thus, during the assembly of a 
WAVE regulatory complex, BRK1 interacts directly with WAVE, ABI and SRA1 proteins 
but not HEM1 protein. Furthermore, we also found that the ARP2 and ARP3 proteins levels 
remained unchanged following suppression of BRK1 consistent with the fact that the ARP2/3 
complex only binds to activated WAVE2 protein at its C-terminal end [7, 10]. Collectively, 
our data suggest that in T cells, miR-181c represses BRK1 expression which in turn 
destabilize proteins in the WAVE2 complex. 
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Upon stimulation of PBMC derived CD3
+
 T cells, we found that the expression of miR-181c 
was significantly reduced and the protein expression of BRK1 was markedly elevated. 
Further overexpression and knockdown studies confirmed that the miR-181c-BRK1 axis is 
important in T cell activation. In addition, we demonstrated that the miR-181c-BRK1 axis 
regulates actin polymerization-dependent processes in T cells such as lamellipodia generation 
and immunological synapse formation.  
Although the role of miR-181c in regulation of actin dynamics in T cells is poorly 
understood, there are several previous studies which showed that the miR-181 family is 
important in T cell activation. miR-181a has been shown to enhance T cell activation by 
downregulating multiple negative regulators (phosphatases such as PTPN22, SHP-2 and 
DUSP6) in the TCR signaling pathway [3]. In addition, downregulation of miR-181c 
expression following T cell activation has been previously reported in Jurkat and PBMC 
derived CD4
+
 T cells [5]. Moreover, ectopic expression of miR-181c in Jurkat and CD4
+
 T 
cells has been shown to reduce T cell activation and proliferation by targeting IL-2 [5].  
It is evident that BRK1 plays a key role in cellular processes that are dependent on actin 
cytoskeleton [26]. For example, BRK1 was shown to be required for lamellipodia formation 
in HeLa cells [21, 27]. Suppression of BRK1 in non-small cell lung carcinoma cell line 
caused actin filament reorganization, inhibited pseudopodia formation and blocked cell 
migration [22]. Loss of BRK1 in renal cell carcinoma and osteosarcoma cell lines also 
resulted in defective directional migration and invasive growth, coupled with reduced cell 
proliferation [23]. Furthermore, BRK1 is also essential in actin dynamics and cell survival 
during embryo development as genetic ablation of Brk1 in mice resulted in dramatic defects 
in embryo compaction and development [23]. In addition, BRK1 regulates actin dynamics 
during the processes of neurite outgrowth in human neuroblastoma [28].  
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Although much remains unknown regarding the role of BRK1 in actin reorganization in T 
cells, the WAVE2 complex has been shown to be important in regulating actin cytoskeletal 
remodeling in T cells. Nolz and colleagues showed that WAVE2 suppression resulted in 
reduction in conjugation formation and F-actin accumulation at the T cell-B cell site, coupled 
with defects in generation of stable lamellipodia in response to anti-TCR ligation [14]. In 
addition, the two members of WAVE2 complex, ABI2 and HEM1, have also been shown to 
be recruited at the immunological synapse site together with WAVE2 and F-actin, and loss of 
HEM1 exhibited significant defects in conjugate formation similar to WAVE2 suppression 
[14]. Moreover, Zipfel et al. demonstrated that ABI co-localizes with WAVE1 and WAVE2 
at the sites of dynamic actin polymerization, including the leading edge of spreading T cells 
and the T cell-B cell conjugation site [15]. Similarly, primary T cell derived from Abi1/Abi2-
deficient mice were also shown to exhibit reduced actin polymerization upon T cell activation 
[15] and Hem1 deficiency in mice has been shown to result in impaired T cell activation, 
adhesion and development as well as defective F-actin polymerization and actin cap 
formation in lymphocytes [29].  
In conclusion, we have showed that miR-181c regulates BRK1 protein expression level, 
however the exact direct or indirect mechanism needs to be further explored. In addition, we 
have also demonstrated the important role of miR-181c-BRK1 axis in actin polymerization-
mediated T cell functions and T cell activation.   
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Figure Legends 
Figure 1. miR-181c regulates BRK1 expression. (A) qPCR analysis of relative miR-181a, 
miR-181b, miR-181c and miR-181d expressions in MCF7, HeLa and Jurkat T cells 
transfected with pBabePuro vector (control), pBabePuro plasmid expressing miR-181a, miR-
181b, miR-181c and miR-181d. (B) qPCR analysis of relative BRK1 mRNA expression in 
MCF7, HeLa and Jurkat T cells following miR-181a, miR-181b, miR-181c and miR-181d 
overexpression. (C) Western blot analysis of BRK1 protein expression in miR-181a, miR-
181b, miR-181c and miR-181d overexpressing MCF7, HeLa and Jurkat T cells. β-ACTIN 
level is used as a loading control. (D) Densitometric quantification of BRK1 protein 
expression level normalized to β-ACTIN from three independent experiments. (E) qPCR 
analysis of relative BRK1 mRNA expression in miR-181c overexpressing MCF7, HeLa and 
Jurkat T cells (control) and in miR-181c overexpressing MCF7, HeLa and Jurkat T cells 
following miR-181c inhibition. (F) Western blot analysis of BRK1 protein expression in miR-
181c overexpressing MCF7, HeLa and Jurkat T cells following miR-181c inhibition. (G) 
Densitometric quantification of BRK1 protein expression level normalized to β-ACTIN from 
two independent experiments. (H) Relative firefly:renilla luciferase activity of BRK1 in miR-
181c overexpressing MCF7, HeLa and Jurkat T cells. Error bars represent mean ± SD. * P 
≤ .05; ** P ≤ .01; ns P=not significant. 
Figure 2. BRK1 is important for stability of WAVE2 regulatory complex in T cells. (A) 
Western blots showing protein expressions of BRK1, WAVE2, ABI1, SRA1, HEM1, ARP2 
and ARP3 in Jurkat and primary T cells transduced with scrambled shRNA (Scrambled) and 
two independent shRNA targeting BRK1 (shBRK1_1 and shBRK1_2). β-ACTIN level is 
used as a loading control and numbers represent the densitometric quantification of protein 
expression levels normalized to β-ACTIN. 
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Figure 3. The miR-181c-BRK1 axis is involved in T cell activation. (A) qPCR analysis of 
relative miR-181c expression in PBMC derived CD3
+
 T cells before and after stimulation 
with 2μg/ml of plate-bound anti-human CD3 and soluble anti-human CD28 antibodies for 24 
hr. (B) Western blot analysis of BRK1 protein expression in PBMC derived CD3
+
 T cells 
before and after stimulation. β-ACTIN level is used as a loading control. (C) Densitometric 
quantification of BRK1 protein expression level normalized to β-ACTIN from two 
independent experiments. (D) qPCR analysis of relative BRK1 mRNA expression in Jurkat T 
cells transduced with scrambled shRNA (Scrambled) and two independent shRNA targeting 
BRK1 (shBRK1_1 and shBRK1_2). (E) CD69 expression in Jurkat T cells transfected with 
pBabePuro vector (control) and pBabePuro plasmid expressing miR-181c before (red) and 
after (blue) stimulation with 10μg/ml plate-bound anti-human CD3 antibody and 25ng/ml 
PMA for 24 hr. (F) Chart showing the quantification of relative MFI of CD69 staining from 
three independent experiments. (G-H) CD69 expression in BRK1-knockdown Jurkat T cells 
before (red) and after (blue) stimulation. (I-J) CD69 and (K-L) CD154 expression in BRK1-
suppressed primary T cells before (red) and after (blue) stimulation with 2μg/ml plate-bound 
anti-human CD3 and soluble anti-human CD28 antibodies for 24 hr. Y-axis indicates cell 
number and x-axis indicates log fluorescence intensity of CD69-PE, Pacific Blue CD69 or 
CD154-PE staining. Error bars represent mean ± SD. * P ≤ .05; ** P ≤ .01; *** P ≤ .001.  
Figure 4. Overexpression of miR-181c and silencing of BRK1 reduced actin 
polymerization in T cells. (A) F-actin staining of miR-181c overexpressing Jurkat T cells 
before (red) and after (blue) stimulation with 10μg/ml plate-bound anti-human CD3 antibody 
and 25ng/ml PMA for 24 hr. Y-axis indicates cell number and x-axis indicates log 
fluorescence intensity of F-actin (rhodamine phalloidin) staining. (B) Chart showing the 
quantification of relative MFI of F-actin staining from three independent experiments. (C-D) 
Plots and charts showing the total F-actin cellular content in Jurkat T cells with BRK1 
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knockdown before (red) and after (blue) stimulation. (E-F) Plots and charts showing the total 
F-actin cellular content in BRK1-suppressed primary T cells before (red) and after (blue) 
stimulation with 2μg/ml plate-bound anti-human CD3 and soluble anti-human CD28 
antibodies for 24 hr. Error bars represent mean ± SD. * P ≤ .05.  
Figure 5. Ectopic expression of miR-181c and suppression of BRK1 caused defective 
lamellipodia formation in response to TCR stimulation during T cell spreading. (A) 
Microscopy images showing the lamellipodia formation in Jurkat T cells during cell 
spreading at 1, 3 and 5 min upon miR-181c overexpression. Cells were fixed, permeabilized, 
blocked and stained with rhodamine phalloidin (red) and DAPI (blue), followed by analysis 
using fluorescence microscopy with a 100× oil objective. (B) Chart showing the percentage 
of spreading at 1, 3 and 5 min. Statistical analysis is performed at 5 min time point. (C-D) 
Microscopy images and charts showing the spreading of Jurkat T cells upon BRK1 silencing. 
Analysis is performed as in panels A-B. (E-F) Microscopy images and charts showing the 
spreading of primary T cells following BRK1 knockdown. Analysis is performed as in panels 
A-B. Error bars represent mean ± SEM. ** P ≤ .01; *** P ≤ .001.  
Figure 6. Enforced expression of miR-181c and depletion of BRK1 impaired 
immunological synapse formation in T cells. (A) Confocal images showing the 
immunological synapse formation between miR-181c overexpressing Jurkat T cells 
(unstained) and superantigen-pulsed MEC-1 B cells (blue). Equal number of Jurkat T cells 
and superantigen-pulsed MEC-1 B cells were centrifuged, incubated, transferred to 
microscopic slides, fixed, permeabilized and blocked. F-actin was stained using rhodamine 
phalloidin (red) and slides were analyzed by confocal microscopy using a 60×/1.40 oil 
objective. (B) Chart showing the quantification of the total area of F-actin at the T cell-B cell 
contact site (white arrows) by NIS-elements imaging software. (C-D) Confocal images and 
charts showing the immunological synapse formation between BRK1-suppressed Jurkat T 
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cells and superantigen-pulsed MEC-1 B cells. Immunological synapse assay is performed and 
analyzed as in panels A-B. (E-F) Confocal images and charts showing the immunological 
synapse formation between BRK1-suppressed primary T cells and superantigen-pulsed MEC-
1 B cells. Immunological synapse assay is performed and analysis is done as in panels A-B. 
Error bars represent mean ± SEM. * P ≤ .05; ** P ≤ .01; *** P ≤ .001.  
 






